Fujifilm has recently announced the establishment of a new company in Italy called “FUJIFILM Healthcare Italia SpA” to enhance its presence in the market and provide value to customers across different sectors. This strategic transformation will enable greater operational flexibility and competitiveness in various markets, including healthcare, digital printing, and imaging solutions.
FUJIFILM Healthcare Italia SpA, led by Managing Director Davide Campari, will align with FUJIFILM Healthcare’s global strategy in Italy. The company will focus on providing unique solutions in endoscopy, medical informatics, ultrasound, in vitro diagnostic devices, X-ray modalities, and CT/MRI. With a growing portfolio of advanced products including digital mammography systems and artificial intelligence applications, the healthcare sector is a key focus for Fujifilm’s growth.
The creation of this new company will further strengthen Fujifilm’s position in the healthcare industry and enable it to offer innovative solutions that meet the needs of customers across different sectors. This strategic transformation is part of Fujifilm’s ongoing commitment to adapt and anticipate changes while prioritizing technology and innovation to contribute positively to society. As Fujifilm celebrates its 90th anniversary, it remains focused on driving long-term growth and providing value to customers and stakeholders across different industries and markets.
Overall, this announcement marks an exciting milestone for Fujifilm as it continues to expand its presence in the Italian market while focusing on delivering innovative solutions that meet the evolving needs of its customers.
